These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery. Mohammad F; Al-Lohedan HA Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580 [TBL] [Abstract][Full Text] [Related]
4. In Situ Biosynthesized Superparamagnetic Iron Oxide Nanoparticles (SPIONS) Induce Efficient Hyperthermia in Cancer Cells. Kaushik S; Thomas J; Panwar V; Ali H; Chopra V; Sharma A; Tomar R; Ghosh D ACS Appl Bio Mater; 2020 Feb; 3(2):779-788. PubMed ID: 35019282 [TBL] [Abstract][Full Text] [Related]
5. Triple Therapy of HER2 Zolata H; Afarideh H; Davani FA Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model. Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427 [TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Hayashi K; Nakamura M; Sakamoto W; Yogo T; Miki H; Ozaki S; Abe M; Matsumoto T; Ishimura K Theranostics; 2013; 3(6):366-76. PubMed ID: 23781284 [TBL] [Abstract][Full Text] [Related]
8. Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Le Renard PE; Buchegger F; Petri-Fink A; Bosman F; Rüfenacht D; Hofmann H; Doelker E; Jordan O Int J Hyperthermia; 2009 May; 25(3):229-39. PubMed ID: 19437238 [TBL] [Abstract][Full Text] [Related]
9. Thermo-responsive nano-in-micro particles for MRI-guided chemotherapy. Zhang Z; Wang Y; Rizk MMI; Liang R; Wells CJR; Gurnani P; Zhou F; Davies GL; Williams GR Biomater Adv; 2022 Mar; 134():112716. PubMed ID: 35581091 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205 [TBL] [Abstract][Full Text] [Related]
11. Theranostic Nanoparticles for MRI-Guided Thermochemotherapy: "Tight" Clustering of Magnetic Nanoparticles Boosts Relaxivity and Heat-Generation Power. Hayashi K; Sato Y; Sakamoto W; Yogo T ACS Biomater Sci Eng; 2017 Jan; 3(1):95-105. PubMed ID: 33429683 [TBL] [Abstract][Full Text] [Related]
12. Theranostic Iron Oxide/Gold Ion Nanoprobes for MR Imaging and Noninvasive RF Hyperthermia. Fazal S; Paul-Prasanth B; Nair SV; Menon D ACS Appl Mater Interfaces; 2017 Aug; 9(34):28260-28272. PubMed ID: 28789518 [TBL] [Abstract][Full Text] [Related]
13. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells. Pernal S; Wu VM; Uskoković V ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880 [TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Huang Y; Mao K; Zhang B; Zhao Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953 [TBL] [Abstract][Full Text] [Related]
15. Kim H; Im PW; Lee C; Hong H; Lee W; Koo C; Park SY; Im HJ; Paek SH; Piao Y RSC Adv; 2023 Jan; 13(5):2803-2810. PubMed ID: 36756446 [TBL] [Abstract][Full Text] [Related]
16. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects. Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404 [TBL] [Abstract][Full Text] [Related]
17. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model. Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597 [TBL] [Abstract][Full Text] [Related]
18. Contribution of a 300 kHz alternating magnetic field on magnetic hyperthermia treatment of HepG2 cells. Wang X; Chen Y; Huang C; Wang X; Zhao L; Zhang X; Tang J Bioelectromagnetics; 2013 Feb; 34(2):95-103. PubMed ID: 23059525 [TBL] [Abstract][Full Text] [Related]
19. Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia. Zhang ZQ; Song SC Biomaterials; 2016 Nov; 106():13-23. PubMed ID: 27543919 [TBL] [Abstract][Full Text] [Related]
20. [Preparation and characterization of citric acid-modified superparamagnetic iron oxide nanoparticles]. Wang H; Qin XY; Li ZY; Zheng ZZ; Fan TY Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):340-346. PubMed ID: 29643537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]